Mumbai, April 28 -- Headquartered in the Czech Republic, Respilon is an innovation-driven nanofiber R&D company.

Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX nanofiber technology.

The two entities would focus on the development of Invisible Patch and Powder-based pharmaceutical delivery formats.

The collaboration includes developing commercialization strategies for relevant APIs and formulations, leveraging nanofiber encapsulation technology.

Amit Raj Sinha, managing director and CEO of Sigachi Industries, said: "Partnering with Respilon aligns perfectly with our vision to deliver next-generation pharmaceutical solutions that improve the...